Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Glioma Treatment Market Size and Forecasts 2020-2030, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease, Treatment Type, Grade, End User, and Geography" report has been added to ResearchAndMarkets.com's offering.
The global glioma treatment market is expected to reach US$ 8.29 billion in 2030 from US$ 4.13 billion in 2022. The market is projected to grow with a CAGR of 9.1% from 2022 to 2030. The market's growth is the increasing prevalence of high-grade gliomas, including aggressive brain tumors such as glioblastomas, anaplastic astrocytomas, and oligodendrogliomas. However, high treatment costs hamper the market's growth to a certain extent.
Market Opportunities of Glioma Treatment Market
Brazil, India, China, Russia, and South Africa are among the fastest-growing economies in the world. The healthcare sectors in these countries and other developing economies are projected to expand rapidly in the coming years. The expected growth is due to changes in customer demand, increased awareness about healthcare services, and a continuous rise in the aging population. The global brain cancer treatment market is likely to grow significantly in the coming years with the proliferation of the healthcare sector.
Factors Hampering Glioma Treatment Market
Treating brain tumors can be expensive, and the high cost of treatments becomes a cause of stress and anxiety for patients. In addition to the treatment cost, people need to bear additional unplanned costs related to patient care. High medical costs compel people to discontinue their treatment plans, which may put their health at risk and lead to further costs in the future. According to the National Library of Medicine, the direct medical costs of newly diagnosed, Temozolomide-treated (TMZ) GBM are substantial in commercially insured patients, with estimated total cumulative costs of ~US$ 268,031. The healthcare costs incurred by patients with malignant brain tumors are 20 times higher than those borne by non-cancer control groups with the same demographics.
Glioma Treatment Market: Segmental Overview
The glioma treatment market is segmented based on type into astrocytoma, oligoastrocytoma, and oligodendroglioma. The astrocytoma segment held the largest market share in 2022. Furthermore, the segment is expected to register the highest CAGR from 2022 to 2030. An upsurge in activities to raise public awareness of this condition and its treatment, coupled with the increasing prevalence of this disease, are among the major factors fueling the glioma treatment market growth. In addition, companies in the market for the anaplastic astrocytoma segment may derive growth opportunities from growing R&D efforts and new, untapped market segments.
Based on treatment, the glioma treatment market is segmented into surgery, chemotherapy, radiation therapy, and others. In 2022, the surgery segment held the market's largest share. Also, the same segment is expected to growing demand at the fastest CAGR from 2022 to 2030, owing to the surgery being the most preferred technique as it removes the tumor completely.
Based on grade, the glioma treatment market is segmented into Low Grade and High Grade. In 2022, the high-grade segment held the market's largest share. Also, the same segment is expected to growing demand at the fastest CAGR from 2022 to 2030. Multiple research studies are underway to understand better high-grade tumors to develop more effective treatments or therapies.
The glioma treatment market is segmented based on end-users into hospitals & clinics, and ambulatory care centres. In 2022, the hospital & clinics segment held the largest market share. Furthermore, the same segment is expected to anticipate growth in demand at the fastest CAGR from 2022 to 2030. Further, the increasing number of hospitals, adoption of advanced diagnostic platforms, and growing accessibility of hospitals in developing nations would offer lucrative opportunities for the growth of the glioma treatment market for the hospital segment during the forecast period.
Glioma Treatment Market: Geographical Overview
North America holds the largest share of the global glioma treatment market, whereas the Asia Pacific is the fastest-growing region in the global glioma treatment market. The market in North America is expected to grow during the forecast period, primarily driven by the increasing prevalence of brain tumors, technological advancements in glioma treatment, and the rising number of smokers. Asia Pacific registered the highest CAGR in the global glioma treatment testing market. The market in the region is expected to grow significantly in countries including China, India, and Japan in the coming years. The Asia Pacific market is expected to grow due to the increasing demand for brain cancer treatments and the rising prevalence of brain tumors. Therefore, the region holds huge potential for the glioma treatment market players to grow during the forecast period.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 182 |
| Forecast Period | 2022-2030 |
| Estimated Market Value (USD) in 2022 | $4.14 Billion |
| Forecasted Market Value (USD) by 2030 | $8.29 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
Key Topics Covered
1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Glioma Treatment Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. Glioma Treatment Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Initiatives by Regional and State Governments to Provide Patients Access to Treatment
5.1.2 Increase in Prevalence of High-Grade Glioma
5.2 Key Market Restraints
5.2.1 High Cost of Diagnosis
5.3 Key Market Opportunities
5.3.1 Advancements in Healthcare Sector in Emerging Economies
5.4 Future Trends
5.4.1 Surge in Drug Approvals for Glioma Treatment
5.5 Impact Analysis:
6. Glioma Treatment Market - Global Market Analysis
6.1 Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
7. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease
7.1 Overview
7.2 Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
7.3 Astrocytoma
7.4 Oligoastrocytoma
7.5 Oligodendroglioma
8. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type
8.1 Overview
8.2 Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
8.3 Surgery
8.4 Chemotherapy
8.5 Radiation Therapy
8.6 Others
9. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade
9.1 Overview
9.2 Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
9.3 Low Grade
9.4 High Grade
10. Global Glioma Treatment Market - Revenue and Forecast to 2030 - by End User
10.1 Overview
10.2 Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospital & Clinics
10.4 Ambulatory Surgical Centers
11. Glioma Treatment Market - Geographical Analysis
11.1 North America Glioma Treatment Market, Revenue and Forecast To 2030
11.2 Europe Glioma Treatment Market, Revenue and Forecast to 2030
11.3 Asia Pacific Glioma Treatment Market, Revenue and Forecast to 2030
11.4 Middle East & Africa Glioma Treatment Market, Revenue and Forecast to 2030
11.5 South & Central America Glioma Treatment Market, Revenue and Forecast to 2030
12. Pre & Post Covid-19 Impact
12.1 Pre & Post Covid-19 Impact
13. Glioma Treatment Market Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.4 Inorganic Developments
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd
14.2 Arbor Pharmaceuticals LLC
14.3 Merck & Co Inc
14.4 Sun Pharmaceutical Industries Ltd
14.5 Amgen Inc
14.6 Teva Pharmaceutical Industries Ltd
14.7 Pfizer Inc
14.8 Amneal Pharmaceuticals Inc
14.9 Karyopharm Therapeutics Inc
14.10 Biocon Ltd
For more information about this report visit https://www.researchandmarkets.com/r/nz8p5a
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
